Heraeus Medical Components has acquired Pulse Systems, which offers high-precision laser processing and manufacturing of nitinol and other metal-based implants and delivery systems.
There is an increasing importance of vascular access and delivery systems to enable new therapies, reported Peter Reimer, president of Heraeus Medical Components, in a news release. “It’s been a direct ask from our customers in recent years, and we are excited to bring aboard the expertise and capabilities of Pulse Systems," he said. "They are located in a key medical technology innovation and incubation hub in the Bay Area, which will also strengthen our global R&D footprint. This move will enable us to deliver greater value and innovation to our interventional device partners.”
Added Geoff Hall, CEO of Pulse Systems: “This move allows Pulse Systems to take advantage of Heraeus’ world-class expertise in materials science, high-volume manufacturing, and global reputation as a medical technology innovator. It expands our capabilities and positions us to better serve our customers.”
Pulse Systems offers contract development and manufacturing to medical device OEMs to support complex implants and delivery systems. The acquisition will extend Heraeus’s capabilities by leveraging Pulse System’s advanced technology, materials expertise and competence in the processing, development and manufacturing of Nitinol and tube-based technologies. Applications include stents, laser-cut hypotubes, and flexible shaft technologies for catheters.
Heraeus Medical Components has acquired three companies in the last 14 months. Reported Nicolas Guggenheim, Head of Business Area Medical Technologies: “This acquisition strategy is an intentional and deliberate approach to expand our overall technology abilities and platforms. Medical technology is changing rapidly, and acquisitions like Pulse Systems enable our customers to bring innovative solutions to the market faster.”